ClearBridge Investments
LXRX icon

ClearBridge Investments’s Lexicon Pharmaceuticals LXRX Stock Holding History

ClearBridge Investments’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,463,262
Closed -$9.2M – 1124
2019
Q2 		$9.2M Buy
1,463,262
+171,132
+13% +$1.02M 0.01% 539
2019
Q1 		$7.18M Buy
1,292,130
+42,540
+3% +$258K 0.01% 554
2018
Q4 		$8.3M Sell
1,249,590
-46,320
-4% -$375K 0.01% 547
2018
Q3 		$13.8M Buy
1,295,910
+1,295,777
+974,268% +$14.8M 0.01% 503
2018
Q2 		$2K Buy
133
+11
+9% +$113 ﹤0.01% 1095
2018
Q1 		$1K Hold
122
– – ﹤0.01% 1139
2017
Q4 		$1K Sell
122
-2,432
-95% -$25.3K ﹤0.01% 1148
2017
Q3 		$31K Buy
2,554
+305
+14% +$4.5K ﹤0.01% 968
2017
Q2 		$37K Buy
2,249
+412
+22% +$6.38K ﹤0.01% 903
2017
Q1 		$26K Buy
+1,837
New +$27.3K ﹤0.01% 970

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments's LXRX Position: Q3 2019 in Review

ClearBridge Investments sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2019, closing a stake of 1,463,262 shares — an estimated $9.2M sold.

ClearBridge Investments first reported a position in LXRX in Q1 2017 and held it in 10 quarters. The position peaked at $13.8M in Q3 2018. 103 funds tracked by Wall St. Rank hold LXRX as of Q3 2019.

  • ClearBridge Investments reported no remaining Lexicon Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • ClearBridge Investments sold 1,463,262 Lexicon Pharmaceuticals shares in Q3 2019, an estimated $9.2M.
  • ClearBridge Investments first reported a position in Lexicon Pharmaceuticals in Q1 2017 and held it in 10 quarters.
  • ClearBridge Investments's Lexicon Pharmaceuticals position peaked at $13.8M in Q3 2018.
  • 103 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2019.

Based on ClearBridge Investments's 13F filing for Q3 2019, filed 14 Nov 2019.